{"name":"Chlordiazepoxide","slug":"chlordiazepoxide","kind":"substance","abbreviations":[],"systematic":null,"aliases":["Methaminodiazepoxide","Librelease","Libritabs","Elenium","Librium","Chlozepid","Clopoxide","Clordiazepoxido","Radepur","Lygen"],"brands":[],"scraped":true,"has_structure":true,"cid":2712,"classes":[{"name":"depressant","href":"/class/depressant"}],"families":[{"name":"benzylamine","href":"/substituted/benzylamine"},{"name":"benzodiazepine","href":"/substituted/benzodiazepine"}],"physical":[{"label":"Molecular mass","value":"299.75 g/mol","copyable":false},{"label":"Melting point","value":"236-236.5","copyable":false},{"label":"Solubility","value":"2000 mg/L","copyable":false},{"label":"Predicted LogP","value":"2.4","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>16</sub>H<sub>14</sub>ClN<sub>3</sub>O","copyable":true},{"label":"IUPAC name","value":"7-chloro-4-hydroxy-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-imine","copyable":true},{"label":"SMILES","value":"CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O","copyable":true},{"label":"InChI","value":"InChI=1S/C16H14ClN3O/c1-18-15-10-20(21)16(11-5-3-2-4-6-11)13-9-12(17)7-8-14(13)19-15/h2-9,21H,10H2,1H3","copyable":true},{"label":"InChIKey","value":"BUCORZSTKDOEKQ-UHFFFAOYSA-N","copyable":true},{"label":"CAS number","value":"58-25-3","copyable":true},{"label":"UNII","value":"6RZ6XEZ3CR","copyable":true},{"label":"PubChem CID","value":"2712","copyable":true}],"pharmacokinetics":[{"label":"Elimination half-life","value":"5–30 hours (Active metabolite desmethyldiazepam 36–200 hours; other active metabolites include oxazepam)","copyable":false},{"label":"Metabolism","value":"Liver","copyable":false},{"label":"Excretion","value":"Kidney","copyable":false},{"label":"Routes of administration","value":"By mouth, intramuscular","copyable":false},{"label":"Dependence liability","value":"High<a href=\"#cite_note-3\"><sup>[3]</sup></a>","copyable":false},{"label":"Addiction liability","value":"Moderate","copyable":false}],"toxicity":[{"kind":"LD50","organisms":[["Rat",[{"kind":"LD50","organism":"Rat","route":"Oral","dose":"537 mg/kg"}]]]}],"dosing":null,"salts":[{"title":"Chlordiazepoxide maleate","name":"maleate","slug":"chlordiazepoxide_maleate","drawn":true},{"title":"Chlordiazepoxide hydrochloride","name":"hydrochloride","slug":"chlordiazepoxide_hydrochloride","drawn":true}],"esters":[],"chirality":"achiral","stereo_type":null,"optical_activity":null,"stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[],"mesh":[],"actives":[],"prodrugs":[],"codrug":false,"interactions":[{"target":"GABRA1","mechanisms":["shared target"],"partners":62,"contraindicated":0},{"target":"GABRA2","mechanisms":["shared target"],"partners":58,"contraindicated":0},{"target":"GABRA3","mechanisms":["shared target"],"partners":58,"contraindicated":0},{"target":"GABRA4","mechanisms":["shared target"],"partners":58,"contraindicated":0},{"target":"GABRA5","mechanisms":["shared target"],"partners":58,"contraindicated":0},{"target":"GABRA6","mechanisms":["shared target"],"partners":58,"contraindicated":0},{"target":"GABRB1","mechanisms":["shared target"],"partners":58,"contraindicated":0},{"target":"GABRB2","mechanisms":["shared target"],"partners":58,"contraindicated":0},{"target":"GABRB3","mechanisms":["shared target"],"partners":58,"contraindicated":0},{"target":"GABRD","mechanisms":["shared target"],"partners":58,"contraindicated":0},{"target":"GABRE","mechanisms":["shared target"],"partners":58,"contraindicated":0},{"target":"GABRG1","mechanisms":["shared target"],"partners":58,"contraindicated":0},{"target":"GABRG2","mechanisms":["shared target"],"partners":58,"contraindicated":0},{"target":"GABRG3","mechanisms":["shared target"],"partners":58,"contraindicated":0},{"target":"GABRP","mechanisms":["shared target"],"partners":58,"contraindicated":0},{"target":"GABRQ","mechanisms":["shared target"],"partners":58,"contraindicated":0}],"mechanism":"Chlordiazepoxide binds to stereospecific benzodiazepine (BZD) binding sites on GABA (A) receptor complexes at several sites within the central nervous system, including the limbic system and reticular formation. This results in an increased binding of the inhibitory neurotransmitter GABA to the GABA(A) receptor. BZDs, therefore, enhance GABA-mediated chloride influx through GABA receptor channels, causing membrane hyperpolarization. The net neuro-inhibitory effects result in the observed sedative, hypnotic, anxiolytic, and muscle relaxant properties.","side_effects":{"drug_id":2712,"drug_name":"chlordiazepoxide","url":"https://sideeffects.embl.de/drugs/2712/pt","atc_codes":["N05BA02"],"side_effects":[{"name":"Agranulocytosis","cui":"C0001824"},{"name":"Ataxia","cui":"C0004134"},{"name":"Confusional state","cui":"C0009676"},{"name":"Feeling abnormal","cui":"C1443060"},{"name":"Constipation","cui":"C0009806"},{"name":"Libido decreased","cui":"C0011124"},{"name":"Disturbance in sexual arousal","cui":"C0855242"},{"name":"Somnolence","cui":"C2830004"},{"name":"Oedema","cui":"C0013604"},{"name":"Blood disorder","cui":"C0018939"},{"name":"Jaundice","cui":"C0022346"},{"name":"Nausea","cui":"C0027497"},{"name":"Dizziness","cui":"C0012833"},{"name":"Shock","cui":"C0036974"},{"name":"Syncope","cui":"C0039070"},{"name":"Loss of consciousness","cui":"C0041657"},{"name":"Hepatic function abnormal","cui":"C0086565"},{"name":"Menstruation irregular","cui":"C0156404"},{"name":"Extrapyramidal disorder","cui":"C0015371"},{"name":"Rash","cui":"C0015230"}],"indications":[{"name":"Alcoholism","cui":"C0001973"},{"name":"Anxiety","cui":"C0003467"},{"name":"Anxiety disorder","cui":"C0003469"},{"name":"Apprehension","cui":"C0233485"},{"name":"Tension","cui":"C0233494"},{"name":"Withdrawal symptom","cui":"C0087169"}]},"effects":null,"usernotes":[],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Australia","status":"Schedule 4","act":null,"refs":[]},{"jurisdiction":"Brazil","status":"B1","act":null,"refs":[4]},{"jurisdiction":"Canada","status":"Schedule IV","act":null,"refs":[]},{"jurisdiction":"United States","status":"Schedule IV","act":"Controlled Substances Act","refs":[]},{"jurisdiction":"Germany","status":"Prescription only/Anlage III","act":null,"refs":[]},{"jurisdiction":"United Kingdom","status":"Class C","act":"Misuse of Drugs Act 1971","refs":[]},{"jurisdiction":"Other","status":"SE: Förteckning IV, In general: ℞ (Prescription only)","act":null,"refs":[5]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Chlordiazepoxide"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/2712"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q106042110"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB00475"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL451"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A94781"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=58-25-3"},{"source":"KEGG","url":"https://www.kegg.jp/entry/D00267"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID40861935"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Chlordiazepoxide"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/6RZ6XEZ3CR"},{"source":"SIDER","url":"https://sideeffects.embl.de/drugs/2712/pt"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 2712, Chlordiazepoxide. Accessed November 20, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/2712>https://pubchem.ncbi.nlm.nih.gov/compound/2712</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Chlordiazepoxide. UNII: 6RZ6XEZ3CR. Global Substance Registration System. Accessed November 20, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/6RZ6XEZ3CR>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/6RZ6XEZ3CR</a>","Edmunds M, Mayhew M. Pharmacology for the Primary Care Provider. Mosby. 2013. <a href='https://books.google.com/books?id=8FwdEsvnw8oC&amp;pg=PA545'>https://books.google.com/books?id=8FwdEsvnw8oC&amp;pg=PA545</a>","RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. <a href='https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992'>https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992</a>","Klordiazepoxid. Läkemedelsverket.se. <a href='https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/substans/e4pobuu91snvert1/klordiazepoxid'>https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/substans/e4pobuu91snvert1/klordiazepoxid</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 17:59:59","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 17:59:55","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 17:59:55","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 17:59:57","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 17:59:55","note":"no HMDB id"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 17:59:59","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 17:59:55","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 17:59:55","note":"no r/tripreports posts mention it"},{"source":"sider","status":"ok","fetched_at":"2026-11-20 17:59:55","note":null},{"source":"structure","status":"ok","fetched_at":"2026-11-20 17:59:55","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 17:59:55","note":null}],"description":"Chlordiazepoxide is a depressant substance."}